BICYCLE THERAPEUTICS PLC
For the period ended Dec 31, 2025. Filed Mar 17, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 17, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
Insider Trading Arrangements
During the three months ended December 31, 2025, our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated the contracts, instructions or written plans for the purchase or sale of our securities set forth in the table below, each of which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (“Rule 10b5-1 Plan”).
| · · · Type of Trading Arrangement · · | ||||||
|---|---|---|---|---|---|---|
| Name and Position | Action | Adoption/Termination Date | Rule 10b5-1 | Non-Rule 10b5-1 | Total Number of Ordinary Shares to be Sold | Expiration Date |
| Charles Swanton, Director(1) | Termination | December 22, 2025 | X | | 3,500 | July 14, 2028 |
| (1) | On December 22, 2025, Charles Swanton, a member of our board of directors, terminated a pre-arranged share trading plan pursuant to Rule 10b5-1, which was adopted on October 14, 2024. The plan provided for the sale of Restricted Share Units that were expected to vest during the term of the 10b5-1 plan until July 14, 2028 or the earlier completion of all authorized transactions under the plan. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.